Karen Aboody
Institution Name:
City of Hope, Beckman Research Institute
Total Awards:
2
Award Value:
$20,763,885
Awards as PI
| Program Type | Institution | Grant Title | Award Value |
|---|---|---|---|
| Disease Team Research I | City of Hope, Beckman Research Institute | Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials | $17,890,623 |
| Therapeutic Translational Research Projects | City of Hope, Beckman Research Institute | Neural Stem cell-mediated oncolytic immunotherapy for ovarian cancer | $2,873,262 |
Total: $20,763,885.00 |
Publications
- PLoS One 2012 Cellular host responses to gliomas. (PubMed: 22539956)
- PLoS One 2012 Contact and encirclement of glioma cells in vitro is an intrinsic behavior of a clonal human neural stem cell line. (PubMed: 23240066)
- Regen Med 2012 Researchers and the translational reality. Interview with Karen Aboody. (PubMed: 23210812)
- Stem Cells Transl Med 2013 Magnetic Resonance Imaging Tracking of Ferumoxytol-Labeled Human Neural Stem Cells: Studies Leading to Clinical Use. (PubMed: 24014682)
- Stem Cells Transl Med 2013 Neural Stem Cell-Mediated Delivery of Irinotecan-Activating Carboxylesterases to Glioma: Implications for Clinical Use. (PubMed: 24167321)
- Future Oncol 2014 Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution. (PubMed: 24559447)
- Mol Ther Oncolytics 2020 Neural Stem Cells Improve the Delivery of Oncolytic Chimeric Orthopoxvirus in a Metastatic Ovarian Cancer Model. (PubMed: 32775617)
- Mol Ther Oncolytics 2019 Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian Cancer. (PubMed: 30719498)
- Proc Natl Acad Sci U S A 2020 Specific targeting of ovarian tumor-associated macrophages by large, anionic nanoparticles. (PubMed: 32732430)
- Stem Cell Res Ther 2021 Allogeneic human neural stem cells for improved therapeutic delivery to peritoneal ovarian cancer. (PubMed: 33761999)
- Cancers (Basel) 2021 Multiple Treatment Cycles of Neural Stem Cell Delivered Oncolytic Adenovirus for the Treatment of Glioblastoma. (PubMed: 34944938)
